Evaluation of a Novel Nasal Conformer in Pediatric Patients

Part of paid clinical trials in Knoxville, Tennessee.

Sponsor
East Tennessee Children's Hospital
Study ID
NCT06885801
Phase
PHASE2
Status
Enrolling By Invitation

Conditions

  • Cleft Lip
  • Nasal Surgical Procedures

Eligibility Criteria

Sex
ALL
Age
N/A - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • use of an anatomically designed nasal conformer — DEVICE
    this study will evaluate the use of a nasal conformer that has been designed to match the internal airway anatomy of the anterior nose rather than the standard hollow, conical conformer currently available on the market

Study Details

This study compares the current commercially available nasal conformer available for use in cleft lip repair and nasal scar release to a novel, anatomically shaped conformer based upon typical nasal airspace shape. This will follow patients using both of these types of splints during the post-operative healing process with one group starting with the standard splint and then moving to the anatomic conformer and the second group beginning with the anatomic and them moving to the standard conformer. This study will evaluate the patient experience and outcomes of the 2 types of conformers, looking at the discomfort, device dislodgements, ease of use and occurrence of complications such as skin irritation and rashes or skin breakdown.

Key Dates

First listed
Mar 20, 2025
Start date
Jun 1, 2025
Status verified
Sep 2026
Primary completion
Jun 1, 2030
Completion
Dec 1, 2030

Study Design

Enrollment
20 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Other: Standard first, anatomic second
    Patients are started with the standard nasal conformer for the first 3 months and then switched to the anatomic conformer for the second 3 months
  • Other: Anatomic first, standard second
    Patients are started with the anatomic nasal conformer for the first 3 months and then switched to the standard conformer for the second 3 months

Primary Outcome Measure

Ease of use [ Time Frame: 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
East Tennessee Children's HospitalKnoxvilleTennessee37916-

Find similar trials in Knoxville, TN

Related Studies